Mohamad Mohty, MD, PhD, attended the University of Montpellier, France, where he completed his medical degree. He then undertook a PhD at the University of Marseille, France, before working at the Hematology Department at Hammersmith Hospital, London, UK.
Prof. Mohty is a Professor of Hematology and Head of the Hematology and Cellular Therapy Department at the Saint-Antoine Hospital and Sorbonne University in Paris, France. He also leads a translational research team (INSERM team) at the Saint-Antoine Research Center, Paris, France. Prof. Mohty is the Chairman of the Acute Leukemia Working Party and past President of the European Society for Blood and Marrow Transplantation (EBMT). He has published over 600 peer-reviewed articles internationally, and lectured in more than 70 countries.
Speaking on pathophysiology and immunobiology of antigen-presenting cells
Prof. Mohty is interested in the pathophysiology and immunobiology of normal and pathological antigen-presenting cells. In particular, his research focuses on the impact of several novel immunomodulatory agents, proteasome inhibitors and hypomethylating agents. As head of the INSERM translational research team, Prof. Mohty has a special clinical focus on immunotherapy and reduced-toxicity conditioning regimens in multiple myeloma and acute leukemia.